Generics Bulletin is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Oklahoma Judge Wants More Details On Teva’s Opioid Settlement

Executive Summary

An Oklahoma judge is withholding approval of the state’s proposed $85m out-of-court opioid settlement with Teva until he gets assurances that it complies with state law.

You may also be interested in...



Volatility Is The New Normal For Industry

Potential liability in US litigation is acting as a lag on valuations for listed generics players and creating market volatility, Wall Street analyst Randall Stanicky says. But while industry faces many challenges, voices of optimism were also raised during the opening to the joint annual conference of Medicines for Europe and the IGBA.

J&J Gambles Oklahoma Opioid Trial Is Better Than Settlement; State Seeks $870m Per Year

In opening statements, Oklahoma suggests award could be 'just shy of $13bn' if it takes 20 years to fix the problem.

Teva Stresses Stability In Settling Oklahoma Opioids Case

Teva says paying $85m to settle claims it contributed to opioid abuse in Oklahoma is important in maintaining the stability of the heavily indebted group.

Topics

Related Companies

Latest News
See All
UsernamePublicRestriction

Register

GB140415

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel